News from NYU Langone Health
NYU Langone Health opens new ambulatory clinic in Clinton Hill
Brooklyn Daily Eagle
NYU Langone Health opened a new ambulatory clinic in Clinton Hill on April 6. The new location, NYU Langone Brooklyn Medical Associates—Clinton Hill, is at 535 Clinton Ave. and includes 25 exam rooms and 17 physicians. Services offered include primary care for adults and children, bariatric surgery, gastroenterology, pediatric cardiology, and pediatric neuropsychology. Women’s health services such as obstetrics and gynecology, family planning, and maternal–fetal medicine are also available. This expansion follows the recent acquisition of three new pediatric practices across the city.
Also reporting: Becker’s ASC Review
4/16/2026
A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment
STAT
An episode of 'The Readout LOUD' podcast will feature an interview with Paul E. Oberstein, MD, a pancreatic cancer specialist, service chief, Gastrointestinal Medical Oncology Program, and assistant director, Pancreatic Cancer Center, Perlmutter Cancer Center. He will discuss Revolution Medicines' experimental drug for pancreatic cancer, which reported a significant survival benefit in a Phase 3 study. The podcast will also cover new results from Allogene Therapeutics for an off-the-shelf CAR-T therapy for B-cell lymphoma.
4/16/2026
E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
HealthDay
A new study reports that battery-driven bicycles and scooters are becoming a public hazard, endangering riders and pedestrians. Research from NYU Grossman School of Medicine, published in the journal Neurosurgery, found that e-bike and e-scooter crashes now account for more than half of related trauma cases at a major New York City hospital. One-third of patients sustained a traumatic brain injury. Lead researcher Hannah Weiss, MD, a neurosurgery resident at NYU Grossman School of Medicine, noted these injuries demand neurosurgical care at an unprecedented scale. Senior researcher Paul Huang, MD, an associate professor of neurosurgery at NYU Grossman School of Medicine, and chief of neurosurgery at NYC Health + Hospitals/Bellevue, added that urban infrastructure has not kept pace with the rise of these vehicles.
Also reporting was: Ex Bulletin, Philly Voice, MedicineNet
4/16/2026
Teen critically hurt on e-bike, as LI doctors ay crashes are on the rise
News 12 Long Island
Doctors on Long Island are seeing an increase in e-bike crashes, with a recent incident leaving a 15-year-old critically injured in Huntington. Katherine A McKenzie, DO, chief of Acute Care Surgery, NYU Langone Hospital—Long Island, states that most riders do not wear helmets, which results in more traumatic brain injuries. According to new research from NYU Langone, brain injuries are responsible for one-third of all electric bike and scooter accidents. Dr. McKenzie also notes that the higher speeds of e-bikes lead to more severe injuries during crashes.
4/16/2026
Ten Rising Neuroscientists Named 2026 Leon Levy Scholars Across New York
SCIENMAG
The New York Academy of Sciences and the Leon Levy Foundation announced the 2026 cohort of Leon Levy Scholars in Neuroscience, which includes several researchers from New York University. From NYU Grossman School of Medicine, the scholars are: Takayoshi Kuwabara, PhD, who studies aggression and fear circuitry; Nathan Nakatsuka, PhD, who uses genomics to research oxycodone addiction; and Mackenna Wollet, PhD, who investigates synaptic plasticity. Other recipients include Joey Charbonneau, PhD, of New York University's Center for Neural Science and Yosif (Joe) Zaki, PhD, of New York University. The program provides three years of funding.
4/16/2026
It Feels Like Everyone Is Using a GLP-1 to Lose 10 or 15 Pounds—Should I?
Glamour
An article on the growing trend of using GLP-1 drugs for cosmetic weight loss features commentary from Alexandra Sowa, MD, a dual board-certified obesity and internal medicine physician and clinical instructor at NYU Grossman School of Medicine. She describes the practice of 'microdosing' as 'messy' but is open to creating bespoke dosing schedules for patients. Dr. Sowa advocates for using body-composition scans over BMI to assess health and warns against using these drugs for crash dieting, noting that weight is often regained after stopping. She expresses concern that the public discourse is focused on 'getting skinny' rather than improving overall health.
Also reporting was: Yahoo Health
4/16/2026
Daily QA 4 Pro redefines machine quality assurance for next-generation radiotherapy
Physics World
A new radiotherapy quality assurance device, the Daily QA 4 Pro by Sun Nuclear, integrates dosimetry and positioning verification into a single platform. David Barbee, PhD, director of Technology and Innovation in Radiation Oncology at NYU Langone Health, and Lead, Health Informatics - Radiation Oncology, MCIT Department of Health Informatics, was an early adopter of the technology. Barbee explained that his team at NYU Langone Health tested the device for surface-guided radiotherapy, dosimetry, and isocenter accuracy. The analysis found the system provides comprehensive data comparable to existing methods while significantly improving workflow efficiency by reducing the time and number of setups required for daily quality assurance checks.
4/16/2026
How Might a Novel Radioenhancer Impact Stage III Unresectable NSCLC Care?
ONCOLOGY journal
In an interview, Benjamin Cooper, MD, an associate professor in the Department of Radiation Oncology at NYU Grossman School of Medicine and director of Proton Therapy Services Radiation Oncology at NYU Langone Health, discussed findings from the phase 2 CONVERGE trial. The study evaluates JNJ-1900, an investigational nanoparticle radioenhancer for stage III unresectable non–small cell lung cancer. Dr. Cooper, also site director of Radiation Oncology at Perlmutter Cancer Center, noted that early data showed the intratumoral therapy was feasible and produced a 71% overall response rate in a small cohort, supporting continued investigation to improve the standard of care.
4/16/2026
Finding Heart Health Warnings on Screening Mammograms
Radiological Society of North America
A study presented at RSNA 2025 by Samantha Platt, MD, a resident in the Department of Radiology at NYU Langone Health, suggests that screening mammograms can serve as an opportunistic screening tool for cardiovascular disease. Researchers found that breast arterial calcifications (BAC) correlate positively with coronary artery calcifications. The study highlighted that the absence of BAC has a high negative predictive value for major adverse cardiovascular events, with a 98% predictive value for myocardial infarction and 97% for coronary revascularization, indicating a very low risk for women without BAC.
4/16/2026
Limited Surgery Trial for Unresectable Pleural Mesothelioma
World Today News
A clinical trial is investigating if limited surgery can improve outcomes for patients with unresectable pleural mesothelioma. Phase II findings showed a median overall survival of 24.3 months in the surgical cohort versus 17.1 months in historical controls. Andrea B. Wolf, MD, of Mount Sinai Health System, noted the goal is to make tumors more susceptible to immunotherapy. Commenting on the results, Harvey I. Pass, MD, the Stephen E. Banner Professor of Thoracic Oncology, and vice chair of Research at the Department of Cardiothoracic Surgery at NYU Grossman School of Medicine, stated that while mesothelioma is a systemic disease, local control can meaningfully alter its trajectory when integrated with modern systemic therapy.
4/16/2026
What Happens When You Go on Ozempic But You’re Already Thin?
The Daily Beast
The use of GLP-1 drugs like Ozempic for cosmetic purposes among people who are not overweight is raising concerns about potential health risks. Thea Gallagher, PsyD, clinical psychologist and director of Wellness Programs in the Department of Psychiatry at NYU Langone Health, notes that Hollywood's return to a 'heroin chic' body ideal impacts what people perceive as beautiful. Priya Jaisinghani, MD, endocrinologist, obesity medicine expert, and clinical assistant professor in the Department of Medicine at NYU Langone Health, warns that these are powerful metabolic medications, not cosmetic supplements, and their misuse can lead to nutritional deficiencies, hormonal disruption, and loss of muscle mass.
4/16/2026
FDA Warns Popular Anxiety Drug Recalled Nationwide
Prevention
The Food and Drug Administration has announced a nationwide voluntary recall for select lots of 3-milligram Xanax XR tablets due to 'failed dissolution specifications.' The distributor, Viatris, initiated the recall out of caution. According to Thea Gallagher, PsyD, clinical associate professor and director of Wellness Programs in the Department of Psychiatry at NYU Langone Health, this failure means the tablets may not break down properly, potentially leading to lower drug absorption and reduced therapeutic effect. She notes that patients might experience inadequate control of their anxiety or panic symptoms, or even withdrawal symptoms due to inconsistent dosing.
4/17/2026
AMJ Podcast | Episode 6: HRD Testing in Action: Expert Views & Real-World Evidence
EMJ- European Medical Journal
A podcast episode on homologous recombination deficiency (HRD) testing in ovarian cancer features Bhavana Pothuri, MD, gynecologic oncologist at NYU Langone Health, associate professor in the Department of Obstetrics and Gynecology at NYU Grossman School of Medicine and director of Gynecologic Oncology Clinical Trials, as an expert guest. The discussion focuses on providing clinicians with guidance on selecting tests, understanding outputs, and integrating results into guideline-aligned care. The podcast, sponsored by AstraZeneca, also covers workflow design across oncology, pathology, and genetics.
4/16/2026
Heart Health Tips Every Woman Should Know for Midlife Wellness
Flow Space
Heart disease is the leading cause of death among women, yet it is often misunderstood and underdiagnosed. Women experience unique risk factors and may present with less specific symptoms than men. Michelle Bloom, MD, director of the cardio-oncology program, and site director, Cardio-Oncology Program, NYU Langone Hospital—Long Island, suggests women are more likely to die after a heart attack partly because they may delay seeking care and their symptoms might not be taken as seriously. She notes that menopause brings physiological changes that increase cardiac risk, such as increased abdominal fat and higher cholesterol, blood sugar, and blood pressure. Dr. Bloom stresses the importance of controlling modifiable risk factors.
4/16/2026
Low-Dose Oral Minoxidil: Hair Growth May Peak After 6 Months, Review Suggests
Medscape
A retrospective review of 178 patients at NYU Langone Health found that low-dose oral minoxidil improved hair density and diameter for those with androgenetic alopecia within three to six months, followed by a stabilization of these gains. The study, co-led by Archie Spindler and Derek Maas, BS MBA, of NYU Grossman School of Medicine, noted that hair diameter showed a slight drop between 12 and 36 months, potentially reflecting disease progression. The authors suggest prospective studies are needed to understand long-term effects.
4/17/2026
Aspirin Unlikely to Cut Colorectal Cancer Incidence
Medscape
A Cochrane Library review of 10 randomized controlled trials found that aspirin likely results in little to no difference in colorectal cancer (CRC) incidence at a follow-up of less than 15 years. The findings suggest any potential prevention benefit is delayed and uncertain, while bleeding risks are well-established. Commenting on the review, Aasma Shaukat, MD, MPH, the Robert M. and Mary H. Glickman Professor of Medicine, Division of Gastroenterology and Hepatology, and director of Outcomes Research for Gastroenterology and Hepatology at NYU Langone Health, said the results align with recent US guidance against using aspirin for CRC prevention and may help dispel false patient expectations about its benefits.
4/17/2026
New cancer cluster feared in N.J. neighborhood
NJ.com
Residents in a Keyport, New Jersey, neighborhood are concerned about a potential cancer cluster, having identified 41 cases near the former Aeromarine landfill. The site has a history of leaching carcinogens like benzene and lead into the surrounding area. Medical experts have called for a formal investigation. The article notes New Jersey's history with contaminated sites, referencing a past NYU Langone Health study that pointed to alarming toxin levels still present at a Ringwood site years after federal regulators had deemed it clean. State agencies are now in discussions about next steps for the Keyport site.
4/17/2026
Can ‘vaccine beers’ help win over anti-vaxxers?
The Drinks Business
A virologist at the National Cancer Institute has developed a brewer's yeast that produces viral proteins, suggesting it could function as an oral vaccine when brewed into beer. After testing the 'vaccine beer' on himself, blood tests showed his body produced antibodies against two types of polyomavirus. The National Institutes of Health rejected his application for formal trials. Commenting on the concept, Arthur Caplan, PhD, medical ethicist at the New York University Grossman School of Medicine, warned that the idea could worsen anti-vaccine sentiments and stated, 'This is not the place for do-it-yourself.'
4/16/2026
259 Things New Yorkers Should Know
Curbed
A guide to New York City life recommends NYU Langone Health’s fertility clinic for individuals considering conceiving with a donor egg. The article notes the clinic allows the use of eggs from approved outside agencies and also offers an in-house egg-donor program.
4/16/2026
